Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Astellas
Astellas
Aveo Oncology to end breast cancer study due to low enrollment
Yahoo/Reuters
Thu, 01/30/14 - 10:07 am
Aveo Oncology
Astellas
tivozanib
breast cancer
clinical trials
Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Motley Fool
Wed, 01/29/14 - 05:46 pm
Medivation
Astellas
JNJ
Zytiga
Xtandi
prostate cancer
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
JNJ
Medivation
prostatce cancer
Astellas
Dendreon
Sanofi
Zytiga
Xtandi
Provenge
FDA warns of heart risks with Astellas' Lexiscan and Adenoscan
Reuters
Wed, 11/20/13 - 11:14 am
FDA
Astellas
Lexiscan
Adenoscan
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
JNJ
Medivation
prostate cancer
Xtandi
Astellas
Zytiga
When Japanese Pharma Report, These American Biotechs React
Motley Fool
Sat, 11/2/13 - 11:22 am
Arena Pharmaceuticals
Medivation
JNJ
Vivus
Astellas
Eisai
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Tue, 10/22/13 - 08:07 am
Medivation
prostate cancer
Astellas
Enzalutamide
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Top-line Data on Astellas' Isavuconazole
Yahoo/Zacks
Tue, 10/1/13 - 06:03 pm
Astellas
isavuconazole
antifungals
Can Xtandi Become the Go-To Prostate Drug?
Motley Fool
Sat, 09/21/13 - 10:29 am
Xtandi
prostate cancer
Medivation
Astellas
These biotech names are ripe for takeover: Cramer
CNBC
Wed, 08/28/13 - 09:50 am
M&A
Amgen
ONYX Pharmaceuticals
Medivation
Astellas
Seattle Genetics
Astellas Launches Xtandi in the UK
Yahoo/Zacks
Sat, 07/13/13 - 11:42 am
Astellas
Xtandi
prostate cancer
Astellas/Vical Start TransVax Phase III Study
Yahoo/Zacks
Fri, 06/28/13 - 10:30 am
CMV
cytomegalovirus
TransVax
clinical trials
Astellas
vaccines
Vical
Seattle Genetics, Astellas affiliate announce co-development of added ADC
The Fly on the Wall
Thu, 06/27/13 - 10:37 am
Seattle Genetics
antibody-drug conjugate
Astellas
ASG-15ME
Agensys
bladder cancer
lung cancer
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Yahoo
Wed, 06/26/13 - 10:44 am
Medivation
Astellas
Enzalutamide
breast cancer
Cytokinetics-Astellas Agree to Develop Muscle Treatments
Bloomberg
Tue, 06/25/13 - 12:22 pm
Astellas
Cytokinetics
muscle weakness
CK-2127107
Astellas' Xtandi approved in EU for prostate cancer
Pharma Times, UK
Mon, 06/24/13 - 10:50 am
Astellas
Xtandi
prostate cancer
Europe
Medivation
Japan's Astellas looks to sell dermatology assets - sources
Reuters
Wed, 06/19/13 - 11:16 am
Japan
dermatology
Astellas
M&A
Orphan Drug Status for Astellas' Candidate
Yahoo/Zacks
Fri, 05/31/13 - 09:36 am
orphan drugs
Astellas
invasive aspergillosis
isavuconazole
Amgen to make move into Japan, takes on Astellas as partner
Yahoo/Reuters
Wed, 05/29/13 - 08:21 am
Japan
Amgen
Astellas
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »